The successful cure of wide gluteal basocellular epithelioma: a combination therapy of imiquimod cream with cryotherapy

Authors

  • Zerrin Ogretmen
  • Secil Engin Uysal
  • Hacer Köksal Onvural

DOI:

https://doi.org/10.66344/jpad.21.2.2011.458

References

Geisse JK, Rich P, Pandya A et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-8.

Oldfield V, Keating GM, Perry CM. Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol 2005; 6: 195-200; discussion 201-2.

Schiessl C, Wolber C, Tauber M et al. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow up. J Drugs Dermatol 2007; 6: 507-13.

Peris K, Campione E, Micantonio T et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005; 31: 318-23.

Shumack S, Robinson J, Kossard S et al. Efficacy of topical 5% imiquimod cream fort the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.

Peris K, Micantonio T, Fargnoli MC et al. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006: 55: 324-7.

Downloads

Published

2016-12-22

How to Cite

1.
Ogretmen Z, Uysal SE, Onvural HK. The successful cure of wide gluteal basocellular epithelioma: a combination therapy of imiquimod cream with cryotherapy. J Pak Assoc Dermatol [Internet]. 2016Dec.22 [cited 2026Apr.12];21(2):130-1. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/458

Issue

Vol. 21 No. 2 (2011): April - June

Section

Short Communications

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.